Superior Hypogastric Nerve Plexus Block With Bupivacaine for Postoperative Pain Reduction Following Robotic Assisted Resection of Endometriosis: A Randomized Control Trial
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Postoperative pain
研究概览
简要总结
Endometriosis is a condition that causes significant pelvic pain and affects 10-15% of reproductive age women. Treatment options area both medical and surgical for pain relief, however with surgical options, past studies have demonstrated a higher risk of surgical complications as well as higher postoperative pain scores in women with endometriosis. Despite attempts to limit narcotic pain medications with enhanced recovery after surgery (ERAS) protocols, persistent opioid use after surgery is a national crisis, and it is important to explore multimodal options for pain relief. Various studies have shown improvement in pain with use of superior hypogastric nerve blocks in gynecologic surgery, but these effects have not yet been examined in the setting of a minimally invasive endometriosis resection.
The goal of this clinical trial is to determine if a superior hypogastric nerve plexus block with 0.25% bupivacaine hydrochloride can decrease postoperative pain and opioid requirements in patients undergoing robotic assisted resection of endometriosis for the first week after surgery.
Researchers will perform a superior hypogastric nerve plexus block by either injecting 0.25% bupivacaine hydrochloride (investigative treatment) or normal saline (placebo) in subjects who are undergoing a robotic assisted resection of endometriosis.
To determine if postoperative pain is reduced, the subject will be asked to rate their pain score on the Visual Analog Scale (VAS) at 0 hours, 2 hours and 4 hours postop while in the Post-anesthesia Care Unit (PACU). They will then document their pain score each day on a form provided to them for 7 days after surgery.
To determine the effect of this research study on postoperative opioid requirements, the subject will be asked to fill out a form documenting how many tablets of an opioid medication they took each day for a total of 7 days after surgery.
详细描述
This clinical study will recruit patients at their preoperative visit. If the surgery is Davinci single incision laparoscopic surgery (or single incision plus one port) for resection endometriosis, the subject will be informed about the clinical trial, as well as risks and benefits of enrolling by the fellow or attending surgeon. The pre-op visit is typically 1-4 weeks before the day of surgery. They can make the decision either the day of the pre-op visit or they can have time to consider it and inform us of their decision on the day of surgery. If they agree to participate in the trial, they will be consented for the procedure and for enrollment in the trial. The subjects that agree will be assigned a number to de-identify data and then randomly assigned to the placebo or interventional treatment group with use of a computer generator (RedCap). The clinician will be aware of the group that they are in but the subject will not be aware of the group assignment.
At the time of enrollment the subject will also be informed that their medical record will be accessed to obtain information from the surgery and demographics. They will be informed that this information will be de-identified and entered into a password protected database called RedCap. The subject information obtained that will be demographics including those obtained from their pre-operative visit clinic note such as: age, race and ethnicity, gravidity/parity, surgical history, preoperative visual analog scale (VAS) score. As well as the information obtained from the operative note: stage of endometriosis diagnosed, additional laparoscopic procedures performed during the surgery, operative time, estimated blood loss, major intraoperative complication, uterine weight, and pathology. Their medical records will be reviewed by members of the surgical team at the time of surgery, at their postoperative visit, and during data analysis, so three times total.
During the case, The trocar used for the robotic single site surgery is the Single-Site port with curved cannulas made for the DaVinci XI single site instruments. This is inserted through one incision in the umbilicus. If the patient has severe endometriosis, a right lower quadrant 8mm trocar is inserted. This is standard of care for robotic assisted single site resection of endometriosis.
For the block portion of the study, the placebo group will have 5cc of 0.9% normal saline injected superficially into the retroperitoneal space overlying the superior hypogastric nerve plexus just distal to the common iliac bifurcation, bilaterally (10cc normal saline total). The nerve plexus bifurcation will be identified by the sacral promontory and the injection region will be approximately 1-2cm below this area bilaterally. The interventional treatment group will have 5cc total of diluted 0.25% bupivacaine hydrochloride injected at the same location (10cc total).
We will perform the superior hypogastric nerve block with 10cc of 0.25% Bupivacaine Hydrochloride as this is the most common analgesic used for this block. Bupivacaine Hydrochloride is FDA approved for subcutaneous nerve blocks at concentrations of 0.25% and 0.50%. The Texas Children's Hospital Pharmacy is familiar with 0.25% Bupivacaine Hydrochloride as it is a commonly used medication in the operating room and is already present in the endometriosis resection set as it is typically injected in the incision sites after the surgery. The subject will be blinded to the group they are randomized to (either placebo or investigative treatment), but the operating room nurses and physicians will not be blinded. The surgical team will look at what group the subject is assigned to before the case and either ask for the nurse to get the 0.25% Bupivacaine Hydrochloride or a saline filled 10cc syringe. If they are In the 0.25% Bupivacaine Hydrochloride group, no additional medication will be ordered as it is already in the set.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
盲法说明
The subject will be told that the study is regarding postoperative pain control and superior hypogastric nerve plexus blocks with bupivacaine hydrochloride and that they will be randomized into the placebo group or the intervention group, but will be blinded to their assignment. They will be informed they have a 50% chance of being randomized to the investigative treatment group and a 50% chance of being chance of being randomized to the placebo group. Risks and benefits of the procedure as well as consent for the procedure will be obtained. The subject will be assigned a number to de-identify the data and then be randomized using a computer generator and RedCap. The practitioner will be aware of the group that is assigned.
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •18-65 years old
- •Scheduled to undergo a robotic assisted resection of endometriosis
排除标准
- •Subjects who are part of a vulnerable population will be excluded including those who are prisoners, younger than 18 years old, pregnant, individuals with mental disabilities or cognitive impairment.
研究组 & 干预措施
Investigative Treatment
During the surgery, the investigative treatment group will have 5cc of diluted 0.25% Bupivacaine Hydrochloride injected into the superficial retroperitoneal area over the superior hypogastric nerve plexus.
干预措施: Bupivacaine Hydrochloride (Drug)
Placebo
During the surgery, the placebo group will have 5cc of 0.9% normal saline injected into the superficial retroperitoneal area over the superior hypogastric nerve plexus.
干预措施: Normal saline (Drug)
结局指标
主要结局
Postoperative pain
时间窗: Postoperative pain level documented at 0, 2 and 4 hours after surgery, then once a day for 7 days after surgery.
Postoperative pain levels as characterized by the Visual Analog Scale (VAS)
次要结局
- Opioid use(The first 7 days after surgery)
研究者
XIAOMING GUAN
Division Chief of Minimally Invasive Gynecologic Surgery
Baylor College of Medicine
